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First published February 5, 2015; doi:10.1152/ajpgi.00420.2014.—High aldehyde
dehydrogenase (ALDH) activity is a feature of stem cells from normal and cancerous
tissues and a reliable universal marker used to isolate them. There are numerous ALDH
isoforms with preferred substrate specificity variably expressed depending on tissue,
cell type, and organelle and cell status. On the other hand, a given substrate may be
metabolized by several enzyme isoforms. Currently ALDH activity is evidenced by
using Aldefluor, a fluorescent substrate likely to be metabolized by numerous ALDH
isoforms. Therefore, isolation techniques based on ALDH activity detection select a
heterogeneous population of stem or progenitor cells. Despite active research in the
field, the precise role(s) of different ALDH isoforms in stem cells remains enigmatic.
Understanding the metabolic role of different ALDH isoform in the control of stem cell
phenotype and cell fate during development, tissue homeostasis, or repair, as well as
carcinogenesis, should open perspectives to significant discoveries in tissue biology. In
this perspective, novel ALDH substrates are being developed. Here we describe how
new substrates could be instrumental for better isolation of cell population with
stemness potential and for defining hierarchy of cell populations in tissue. Finally, we
speculate on other potential applications.
AldeRed-588-A; Aldefluor; ALDH activity; liver progenitor cell
STEM CELLS (and their cancerous counterparts) are being exten-
sively investigated for regenerative medicine and therapeutic
targeting. They can be used as a direct cell source for regenerative
medicine. They also provide experimental models for target dis-
covery, toxicity testing, and drug screening. The ability to prepare
pure, undamaged, and functional stem cells is a critical step for all
such applications. Identification and isolation of these rarely
occurring cell populations is challenging, and development of
novel labeling approaches is needed to improve their detection
and isolation, as an alternative to transgenic methods that preclude
further utilization for regenerative medicine.
Aldefluor Assay: One of the Main Driving Technologies To
Identify Stem Cells
Increasing evidence suggests that aldehyde dehydrogenase
(ALDH) activity is a reliable universal marker of stem cells
and techniques based on presence and level of ALDH activity
are used for sorting stem cells out of various normal and
cancerous tissues [see reviews (2, 4, 9, 18, 22)]. ALDH is a
family of enzymes with oxidoreductase activity implicated in
many biological processes important for cell survival and cell
protection such as lipid metabolism or detoxification of endog-
enous and exogenous hazardous aldehyde by-products (20, 28).
ALDH activity is important for the development of epithelial
homeostasis and, as a result, deregulation of this class of
enzymes has been implicated in multiple cancers (2, 20).
Aldehydes are widespread organic compounds found in the
environment as well as endogenously formed during the me-
tabolism of alcohols, amino acids, vitamins, retinoids, steroids
and lipid peroxides, xenobiotics (e.g., acetaminophen, cyclo-
phosphamide), and environmental toxics (e.g., cigarette smoke,
motor vehicle fumes). Aldehydes are strong electrophilic com-
pounds with terminal carbonyl groups that can form adducts
with cellular components (proteins and nucleic acids), thereby
initiating adverse biological effects, i.e., loss of protein activity
and mutation of nucleic acids. Hence, disposal of aldehyde is
a priority for cell protection and survival (28), even more so for
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long-living cells such as stem and progenitor cells. Hence,
detection of high ALDH activity has been extensively used as
a tool for stem cell isolation of different organs (2, 4, 9, 18, 22).
Next to this application, our understanding of the biological
function and consequences of ALDH activity in controlling
stemness, activation, amplification, differentiation, and fate of
this discrete cell population is limited.
The currently available commercial assay identifies ALDHbright
cells (cells with high ALDH activity) as those actively
metabolizing Bodipy-amino-acetaldehyde, Aldefluor re-
agent (Aldagen; distributed by Stem Cell Technologies).
This assay is highly sensitive, reproducible, nontoxic, and
easy to use provided that you have access to a fluorescence-
activated cell sorter (FACS). Aldefluor does not involve
antibody recognition or the use of DNA-intercalating dyes
and is also applicable to human material (8). Cytoplasmic
enzyme activity detection has an advantage over antibody-
based detection of cell membrane proteins because such
activity is less likely to be damaged by enzymatic digestion
and processing of the tissues, which are necessary steps for
live single cell isolations. ALDH activity is detected by a
fluorescent green emission, a technical limitation for cell
sorting in organs (such as the liver) rich in endogenous
fluorophores (flavins, NADPH) that autofluoresce in the
green wavelength (480 –580 nm). Green emission also
reduces considerably the choice of combining fluorescently
labeled antibodies to further fractionate the ALDHbright
population and preclude its use for cell isolation in tissues
from green fluorescent protein (GFP) transgenic mice. An
inevitable overlapping of green fluorescence emission into
other channels is also problematic, and therefore “contam-
ination” of ALDH expressing cells in other lineages can be
high.
Numerous studies have documented the presence of
ALDHbright cells in several adult tissues and demonstrated that
these cells carry significant stem/progenitor characteristics in-
cluding stem cell markers, proliferative potential, sphere for-
mation, clonogenicity, and multilineage differentiation. For
example, sorting on ALDH activity enriches cell preparations
for centroacinar and terminal ductal epithelial stem cells from
mouse pancreas (25), for proximal airway basal (13) and
prostatic stem cells (6), but also for hematopoietic (3, 11),
breast (12), skeletal muscle (16), neural tissue (7), and colon
(14) stem cells. Using this technique, we successfully identified
an ALDHbright population with features of hepatic stem/pro-
genitor cells (HSPCs) in healthy mouse and human liver tissue
(8). ALDHbright putative HSPCs were estimated to comprise
2% of the nonparenchymal cell fraction in mouse livers and
35% of this sorted subpopulation exhibit stem cell features
(K19, EpCAM, Sox9, and CD29) (8). Remarkably,
about 5% cells in the low-ALDH-activity fraction (or ALDH-
dim) share stem cell markers as well, indicating that putative
progenitors have escaped from detection by Aldefluor. It is
currently unknown whether these cells express ALDH isoen-
zyme(s) with no or low affinity for the Aldefluor substrate, or
with no or low overall ALDH activity, or represent a subpop-
ulation of cells that have switched ALDH activity owing to, for
instance, lineage specification or commitment. This illustrates
perfectly the limitation of using a single ALDH substrate and
green fluorescence emission.
AldeRed-588-A: Another Alternative to Aldefluor for
Detecting ALDH Activity
By their recent publication in Nature Communications,
Minn and collaborators (21) rejuvenated the interest in using
ALDH activity. They described a new red-shifted fluorescent
ALDH substrate (AldeRed-588-A), for labeling of viable AL-
DHbright cell populations. Structurally, Aldefluor (or Bo-
dipy493/503-aminoacetaldehyde) and AldeRed-588-A (or Bo-
dipy576/589-aminoacetaldehyde) have a common substrate
moiety: acetaldehyde, indicating that a cell oxidizing Aldefluor
is likely to have the same ability to metabolize the AldeRed-
588-A substrate (Fig. 1A). In other words, AldeRed-588-A is
considered as one of the other alternatives to Aldefluor sub-
strate, without other functionally different characteristics. El-
egantly, using cell lines known to express functional ALDH
the authors demonstrated that Aldefluor and AldeRed-588-A
essentially have the same efficacy and efficiency for identify-
ing a ALDHbright population (21). In addition, by successfully
mixing two substrates, Minn and colleagues prove that labeling
technique does not impede the structural recognition of the
substrate by ALDH enzyme and that cell isolation of ALDH
expressing cells is feasible by a single-step isolation method
(Aldefluor and AldeRed-588-A are incubated simultaneously),
thus avoiding additional purification or enrichment steps in
which cells can be lost or damaged. This new AldeRed-588-A
substrate has a broad emission spectrum, which currently
precludes combination with a large array of fluorophores.
Nevertheless, the technical innovation opens new avenues for
stem cell research by offering a greater flexibility for ALDHbright
cell isolations.
Minn and coworkers (21) also proposed a protocol for using
AldeRed-588-A with transgenic mice expressing enhanced-
GFP, which is not an option with the Aldefluor green substrate
because the emission spectra overlap. On the contrary, Al-
deRed-588-A can be used for multicolor applications to frac-
tionate ALDHbright cell populations in the presence of green
fluorophores including the Aldefluor reagent itself or those
cells expressing enhanced GFP (Fig. 1B). This is an important
breakthrough in the field of stem cell biology, because the
maturation and cell fate processes occurring during cell deter-
mination are often visualized by the tracking of the initial
genetically labeled stem cells (by using fluorescent reporters
such as GFP activated by Cre, for example) (5).
Beyond providing a useful tool to identify and isolate stem
cells from different tissues, the authors show the real possibil-
ity of synthetizing functional substrates for ALDH enzymes.
One could thus generate a library of fluorescently distinct
substrates able to discriminate and fractionate stem cell popu-
lations by flow cytometry based on expression of specific
ALDH isoenzymes (Fig. 1C). To act as a functional probe for
ALDH, a compound should possess three important traits (21):
an aldehyde moiety (“the substrate” recognized by the en-
zyme); a hydrophobic moiety for allowing free diffusion into
any cells (supported by the Bodipy dye derivatives); and the
capacity for further trapping within the cytoplasm (presumably
by the different chemical groups linked to the Bodipy core)
following conversion of the aldehyde into the corresponding
carboxylic acid by ALDH. There are several possibilities in the
choice of Bodipy dyes, and several studies have elucidated the
importance of chemical groups on the Bodipy core to achieve
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and improve further functionality (e.g., water solubility, mem-
brane permeability, narrowed wavelength absorption and flu-
orescence emission bands, compatibility with living cells, or
long fluorescence lifetimes) (30, 31). The choice of the ALDH
substrate, which would be linked to the Bodipy dye, will
determine the binding affinity and specificity of the ALDH
isoform (Fig. 1C). One substrate is likely to be metabolized by
several ALDH isoforms and a given isoform is able to metab-
olize structurally diverse substrates. This infidelity makes it
likely that any current ALDH assay is reflecting broad ALDH
activity, with no discrimination between enzyme isoforms, and
thus likely to identify different cellular subsets (17, 19, 20).
Negativity of the assay may attest the absence of ALDH
expression or, conversely, the expression of an enzyme toward
which the tested substrate has no affinity. Indeed, ALDH
activity has been related to different ALDH isoforms in differ-
ent organs: ALDH1A1, ALDH2, ALDH3A1, and ALDH9A1 in
hematopoietic tissue; ALDH1A1 and ALDH1A7 in pancreas
(25); ALDH1/2 and ALDH3A1 in prostate (6); ALDH1A3,
ALDH2, ALDH4A1, and ALDH5A1 in breast tissue (19); and
ALDH1A1 in liver (8). Aldefluor and AldRed-588-A have
been designed to detect a large array of ALDH enzymes and so
a lack of isoform specificity is particularly problematic. One
could envision differentially labeled ALDH isoform-specific
substrates to create a library of probes to functionally discrete
populations of cells expressing specific ALDH isoforms (Fig.
1, C and D). Such a strategy, already highlighted by Minn and
coworkers (21), would help in fractionating different popula-
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tions of cells and relate ALDH isoform expression to pheno-
type or physiological state but obviously needs further inves-
tigation and validation.
Opportunities of Refining the Maturational Lineage Biology
of Stem Cells and Their Progeny
A burning question in the stem cell field is whether progen-
itor cells need ALDH activity to fulfill their role or whether this
activity is biologically inconsequential and only offers a con-
venient way to isolate a cell population with stem cell capac-
ities. Obviously, ALDHs participate in many important bio-
synthetic processes implicated in cell protection from endog-
enous and exogenous aldehyde substrates (28, 29). However,
the high expression levels of ALDHs in various tissues suggest
that these enzymes have additional pivotal roles. Accumulating
evidence suggests that the stem cell and/or tissue repair activity
is influenced by the ALDH activity through production of
retinoic acid, which has a potent biological activity (2, 9, 18,
20). Furthermore, ALDH activity is frequently required for cell
proliferation, differentiation, and response to oxidative stress
(4, 9, 19). Thus, besides acting as cell protectant, ALDH
activity could be important for maintaining cellular integrity as
well as regulating cell turnover and response. There are few
studies exploring a role of ALDH activity in cell fate decision.
One of the biggest reasons for this is the inability to trace the
fate of stem cells concurrently with modulation of ALDH
activity, to address whether these enzymes have a functional
consequence for stemness and/or differentiation capacity.
In recent years work using tracing of precursor cell popula-
tions to adult fates has begun to shed light on the mechanisms
and dynamics of stem/progenitor cell fate determination during
development, tissue maintenance, and repair, as well as their
dysregulation during carcinogenesis (5). Combining such tools
with ALDH activity detection by using the next generation of
substrates based on the AldeRed-588-A synthesis (21) could
offer an important clue to relate the role ALDH activity in
stem/progenitor cells biology, in their lineage organization,
and/or in influencing the lineage restriction choices as they
transit into progenitor cells and then mature cell types. In our
previous studies, we were able to detect ALDH in the canals of
Hering and in bile duct epithelial cells, the putative hepatic
stem cell niche under normal, healthy physiological conditions
(8). A distinct pattern of expression was observed following
liver injury of any etiology: we found fast upregulation of the
ALDH1A1 protein, followed by a return to regular expression
once injury had resolved. This observation is compatible with
the proposition that mature cells were generated from this
ALDHbright pool. Subsequently, we found that ALDH activity
itself follows the same kinetics as the protein (Dollé L, van
Grunsven LA, unpublished data), suggesting a potential rela-
tionship between ALDH activity and lineage commitment of
hepatic stem/progenitors.
Figure 2A illustrates the general representation of the cell
fate determination of the HSPCs to the hepatocytic lineage and
their organization. Recently, OPN-iCreERT2;ROSA26RYFP
mice have been used to determine the fate of these cells, which
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yielded functional hepatocytes in response to chronic liver
injury (10). Additional genetic constructs have then been
developed (15, 24, 26) illustrating the feasibility to trace the
HSPC fate in adult tissues by use of multiple putative stem cell
markers. The eventual reconstitution of the cell fate can be
seen by sorting yellow fluorescent protein (YFP) fractions at
different periods of injury, with no information about ALDH
activity in these cells along their differentiation axis (Fig. 2B).
Combination of ALDH activity (by using a red substrate) with
YFP detection by flow cytometry on cells coming from OPN-
iCreERT2;ROSA26RYFP mice, for example, would allow an
additional fractionation of the YFP population based on
ALDH copositivity. Indeed, the use of red substrate would
enable one to determine which cells have ALDH activity
(ALDHbright) vs. the ones without (ALDHdim); it would then be
possible to better characterize which fraction (ALDHbright or
ALDHdim) correlates with a particular phenotype and to eval-
uate the potency of these subpopulations in vivo. This dynamic
functional reconstitution allows then a better understanding of
the regulators of cell fate compared with YFP cells alone
(Fig. 2C). It is tempting to anticipate that the new generation of
ALDH substrates will enable to discriminate cells expressing
distinct ALDH isoform, including in the ALDHdim population,
and thereby provide tools to address the functional relevance of
ALDH isoenzyme expression profiles for stem cell mainte-
nance, lineage commitment, and cell fate. If indeed a shift in
ALDH activity is instrumental in modifying cell behavior, then
targeted modulation of the activity of this family of enzymes
could be used for therapeutic purposes.
Additional Benefits of Considering New ALDH Substrates
Exploiting the differences in isospecificity of new ALDH
substrates may subsequently facilitate the design of new inhib-
itors selective for each isoform, which would allow, perhaps
for the first time, modulation of the ALDH isoenzymes to favor
a particular lineage outcome in HSPCs and other adult stem
and progenitor cells. Additional benefits from identifying new
ALDH substrates or inhibitors might greatly impact other
fields, like cancer research and clinical diagnosis. ALDHs
participate in multiple metabolic pathways and play a role in
several cancerous disease states, including cancer chemoresis-
tance, by metabolizing activated forms of oxazaphosphorine
drugs. Among them, cyclophosphamide, mafosfamide, or an-
alogs have been widely used for treatment of solid tumors but
their efficacy is limited owing to resistance convened by
overexpression or stabilization of ALDHs. Recognition, con-
ception, and design of new ALDH inhibitors or competitive
substrates could then be helpful in overcoming this escape
mechanism to chemotherapeutic agents (23). Since early de-
tection of cancer is key for curative treatment, there is consid-
erable interest in noninvasive and inexpensive cancer diagno-
sis. Targeting ALDH as a potential approach for cancer cell
labeling might be an appropriate “tracer” for discerning drug-
sensitive and drug-resistant phenotypes of cancers to evaluate
the effectiveness of novel therapies (27). Ultimately, targeted
killing of a cell, based upon its specialized metabolic state
(here ALDH activity), may be useful for clinical application to
preferentially target those rapidly proliferating cells for growth
inhibition or death, as has been described in the case of
threonine dehydrogenase in mouse embryonic stem cells (1). In
the field of cell therapy, tools for tracing transplanted cells are
needed. Therefore, use of ALDH activity markers as imaging
agents for assessing stem cell migration, engraftment, and
expansion in vivo could greatly facilitate our understanding of
the mechanisms of stem cell homing.
Concluding Remarks and Future Directions
The understanding of the function of ALDHs in stem cell
systems is underdeveloped, particularly given the broad range
of cell types that have been isolated on the basis of ALDH
activity by using the Aldefluor assay. Recent work by Minn et
al. (21) not only describes the coupling of aminoacetaldehyde
to a red fluophore (Bodipy 578/589) while maintaining the
same specificity as the well-known Aldefluor substrate but also
paves the way for the generation of a wide portfolio of ALDH
substrates (coupled to different colors), which would facilitate
functional studies of different ALDH isozymes in a variety of
cellular settings. A better understanding of how ALDH isoen-
zymes mark (stem) cell populations of any organ will undoubt-
edly offer a robust and efficient approach for the isolation of
these cells and their potential use in regenerative medicine
(Fig. 2).
The generation of potentially new isoenzyme-specific ALDH sub-
strates might lead to the discovery of new selective ALDH
inhibitors, which will have far-reaching implications for tissue
homeostasis and repair. Understanding the molecular mecha-
nisms in which different ALDH isoforms actively play a role,
in both normal and cancerous tissues, as well as the precise
identification of specific ALDH isoforms prevalent in certain
tumors, will have major diagnostic and prognostic implica-
tions.
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